Merck to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference Call on February 4 Pharmaceutical Investing
Risankizumab Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease Biotech Investing
Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy Pharmaceutical Investing
ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology Pharmaceutical Investing
Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products Cannabis Investing News
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors Biotech Investing
